[144] Sight Sciences, Inc. SEC Filing

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) filed a Form 144, providing notice of a proposed sale of restricted securities by an affiliate. The filing covers the planned disposition of 9,160 common shares, valued at approximately $38,235.67 based on prevailing market prices. The shares, which vested as restricted-stock compensation on 06/30/2025, are slated to be sold through Fidelity Brokerage Services on or about 07/03/2025 on NASDAQ.

With 51.7 million shares outstanding, the contemplated sale represents less than 0.02 % of total shares and therefore is unlikely to have a material impact on the float or trading dynamics. The filer reported no other insider sales in the past three months. While Form 144 sales signal insider liquidity activity, the modest size and compensation-related origin suggest routine portfolio management rather than a directional view on the company’s fundamentals.

Insights

Financial Analyst

TL;DR: Small insider sale (9,160 shares, <0.02 %)—routine, immaterial for valuation.

The Form 144 signals an upcoming insider sale stemming from restricted-stock vesting. At roughly $38 k, the transaction is de-minimis relative to Sight Sciences’ market capitalization and daily trading volume. No aggregation of prior sales was required, indicating limited ongoing insider selling pressure. Such routine liquidity events typically have negligible valuation impact but can be monitored for trend changes if additional filings emerge.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9160	38235.67	51702088	07/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2025	Restricted Stock Vesting	Issuer			9160	06/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Sight Sciences (SGHT) shares are covered by this Form 144 filing?

9,160 common shares are proposed for sale.

What is the aggregate market value of the SGHT shares to be sold?

The filing lists an aggregate value of $38,235.67.

When is the approximate sale date for the SGHT shares?

The sale is expected on or about 07/03/2025.

What percentage of outstanding SGHT shares does the sale represent?

Less than 0.02 % of the 51,702,088 shares outstanding.

How were the shares acquired by the insider?

They vested as restricted-stock compensation on 06/30/2025.

Have there been other insider sales of SGHT stock in the last three months?

The Form 144 reports no other sales during the past three months.